Nothing Special   »   [go: up one dir, main page]

Next Issue
Volume 14, January-2
Previous Issue
Volume 13, December
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
nutrients-logo

Journal Browser

Journal Browser

Nutrients, Volume 14, Issue 1 (January-1 2022) – 231 articles

Cover Story (view full-size image): Growing evidence supports the importance of lifestyle and environmental exposures—collectively referred to as the 'exposome'—for ensuring immune health. In this narrative review, we summarize and discuss the effects of the different exposome components (physical activity, body weight management, diet, sun exposure, stress, sleep and circadian rhythms, pollution, smoking, and gut microbiome) on immune function and inflammation, particularly in the context of the current coronavirus disease 2019 (COVID-19) pandemic. We highlight the potential role of 'exposome improvements' in the prevention—or amelioration, once established—of this disease as well as their effect on the response to vaccination. In light of the existing evidence, the promotion of a healthy exposome should be a cornerstone in the prevention and management of the COVID-19 pandemic and other eventual pandemics. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
24 pages, 6986 KiB  
Article
Curcumin Supplementation (Meriva®) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease
by Francesca Pivari, Alessandra Mingione, Giada Piazzini, Camilla Ceccarani, Emerenziana Ottaviano, Caterina Brasacchio, Michele Dei Cas, Margherita Vischi, Mario Gennaro Cozzolino, Paolo Fogagnolo, Antonella Riva, Giovanna Petrangolini, Luigi Barrea, Laura Di Renzo, Elisa Borghi, Paola Signorelli, Rita Paroni and Laura Soldati
Nutrients 2022, 14(1), 231; https://doi.org/10.3390/nu14010231 - 5 Jan 2022
Cited by 51 | Viewed by 12948
Abstract
Chronic kidney disease (CKD) subjects suffer from high risk of cardiovascular mortality, and any intervention preventing the progression of CKD may have an enormous impact on public health. In the last decade, there has been growing awareness that the gut microbiota (GM) can [...] Read more.
Chronic kidney disease (CKD) subjects suffer from high risk of cardiovascular mortality, and any intervention preventing the progression of CKD may have an enormous impact on public health. In the last decade, there has been growing awareness that the gut microbiota (GM) can play a pivotal role in controlling the pathogenesis of systemic inflammatory state and CKD progression. To ameliorate the quality of life in CKD subjects, the use of dietary supplements has increased over time. Among those, curcumin has demonstrated significant in vitro anti-inflammatory properties. In this pilot study, 24 CKD patients and 20 healthy volunteers were recruited. CKD patients followed nutritional counselling and were supplemented with curcumin (Meriva®) for six months. Different parameters were evaluated at baseline and after 3–6 months: uremic toxins, metagenomic of GM, and nutritional, inflammatory, and oxidative status. Curcumin significantly reduced plasma pro-inflammatory mediators (CCL-2, IFN-γ, and IL-4) and lipid peroxidation. Regarding GM, after 6 months of curcumin supplementation, Escherichia-Shigella was significantly lower, while Lachnoclostridium was significant higher. Notably, at family level, Lactobacillaceae spp. were found significantly higher in the last 3 months of supplementation. No adverse events were observed in the supplemented group, confirming the good safety profile of curcumin phytosome after long-term administration. Full article
(This article belongs to the Special Issue Gut Microbiota in Human Health and Diseases)
Show Figures

Figure 1

Figure 1
<p>Effects of Meriva<sup>®</sup> supplementation on fat mass (FM), fat-free mass (FFM), and BMI: comparison between baseline (CKD T0), after 3 months supplementation (CKD T1), and after 6 months supplementation (CKD T2); ** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>(<b>A</b>) Three months curcumin supplementation decreases MCP-1 (CCL-2) plasma levels in CKD patients; ** <span class="html-italic">p</span> &lt; 0.01. (<b>B</b>,<b>C</b>) Six months curcumin supplementation decreases IFN-γ and IL-4 plasma levels in CKD patients; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>Curcumin supplementation decreases lipid peroxidation in plasma of CKD patients. (<b>A</b>) average values of lipid peroxidation (normalized to baseline values, CKD T0) after 3 months (CKD T1) and 6 months (CKD T2) supplementation. (<b>B</b>) Examples of intra-individual lipid peroxidation changes after Meriva<sup>®</sup> supplementation; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>Uremic toxins levels in plasma of CKD patients. (<b>A</b>) Total (upper) and free (lower) levels of indoxyl sulfate (IS). (<b>B</b>) Total (upper) and free (lower) levels of p-cresyl sulfate (PCS).</p>
Full article ">Figure 5
<p>Biodiversity and phylogenetic analysis between cohorts. Bacterial ecological diversity was assessed between CTRL group (grey), CKD group at baseline (green), and CKD groups supplemented with curcumin (CKD T1, yellow; CKD T2, orange). (<b>A</b>) Alpha-diversity analysis with Chao1, observed species (OTU count), Shannon index, and Faith’s phylogenetic tree metrics. (<b>B</b>) Principal coordinates analysis showing the unweighted Unifrac beta-diversity; the first and second principal coordinates (PCoA1 and PCoA2) are reported.</p>
Full article ">Figure 6
<p>Taxonomic composition of CTRL subjects and CKD patients before curcumin supplementation. Barplots of average microbial relative abundances at family (<b>A</b>) and genus (<b>B</b>) level for healthy subjects (CTRL) and CKD patients alone (T0).</p>
Full article ">Figure 7
<p>Taxonomic composition of the gut microbiota of healthy subjects and CKD at baseline. Barplots of average microbial relative abundances at family level for the control group (CTRL) and CKD patients after 3 and 6 months of Meriva<sup>®</sup> supplementation (respectively, CKD T1 and T2) grouped together.</p>
Full article ">Figure 8
<p>Taxonomic composition of the CKD gut microbiota at family level. Barplots of average microbial relative abundances at family level for CKD patients at baseline (CKD T0) and after 3 and 6 months of Meriva<sup>®</sup> supplementation (respectively, CKD T1 and T2).</p>
Full article ">Figure 9
<p>Co-abundant analysis of the main bacterial families and clinical parameters. Co-abundances have been elaborated through Spearman correlation and are shown as R values reporting co-absence (blue) of bacterial and clinical parameter abundances; co-presence of both (red).</p>
Full article ">Scheme 1
<p>CONSORT flow diagram. CKD patients, chronic kidney disease patients; T0, baseline; T1, after 3 months; T2, after 6 months.</p>
Full article ">
19 pages, 1940 KiB  
Article
Labelling Assessment of Greek “Quality Label” Prepacked Cheeses as the Basis for a Branded Food Composition Database
by Evangelia Katsouri, Antonios Zampelas, Eleftherios H. Drosinos and George-John E. Nychas
Nutrients 2022, 14(1), 230; https://doi.org/10.3390/nu14010230 - 5 Jan 2022
Cited by 6 | Viewed by 3632
Abstract
A labelling assessment study of Greek prepacked “quality label” cheeses was conducted with a view to provide an overview of the whole category. In total, 158 prepacked products belonging to 19 “quality label” cheeses were identified in the Greek market. Among them, Feta [...] Read more.
A labelling assessment study of Greek prepacked “quality label” cheeses was conducted with a view to provide an overview of the whole category. In total, 158 prepacked products belonging to 19 “quality label” cheeses were identified in the Greek market. Among them, Feta had the highest share followed by Kasseri, Graviera Kritis, Kefalograviera and Ladotyri Mitilinis with 81, 16, 15, 11 and 9 products found in the market, respectively. For the rest of the 14 cheeses, the share was limited, ranging from 1 to 4. All labelling indications, nutritional information, claims and other labelling data were recorded and analysed in relation to their compliance against European food law requirements. The results of the analysis showed that for only 6 of the 19 cheeses, all products fully complied with EU labelling legislation. Among the 14 mandatory labelling requirements, the lowest overall compliance was observed for allergens declaration (65%). The analysis of the nutritional data showed a remarkable variability between cheeses and products. Differences in the nutritional characteristics were more pronounced among soft, semi-hard, hard and whey cheese. The above data were entered into an archival database. Application of global harmonisation and standardisation guidelines and tools lead to the initialisation of a branded food composition database (BFCD), conceptualising a specialised database for “quality label” foods. Full article
(This article belongs to the Special Issue Impact of Front of Pack Nutrition Label on Nutritional Behavior)
Show Figures

Figure 1

Figure 1
<p>Geographical Indication (GI) marks: Protected Designation of Origin (PDO) mark and Protected Geographical Indication (PGI) mark.</p>
Full article ">Figure 2
<p>Number of records per food category, for Greece on e-Ambrosia, the EU geographical indications food register. PDO: Protected Designation of Origin, PGI: Protected Geographical Indication (PGI) mark.</p>
Full article ">Figure 3
<p>Flow-diagram presenting methodology for label data collection and structure.</p>
Full article ">Figure 4
<p>Tree map of the distribution of Greek “Quality label” cheese products identified in the retail market and grouped per cheese and firmness category. Fe: Feta PDO, KL: Kalathaki Limnou PDO, Ga: Galotyri PDO, KD: Katiki Domokou PDO, Ko: Kopanisti PDO, An: Anevato PDO, PC: Pichtogalo Chanion PDO, XS: Xigalo Siteias PDO, GK: Graviera Kritis PDO, GN: Graviera Naxou PDO, Ke: Kefalograviera PDO, LM: Ladotyri Mytilinis PDO, Ba: Batzos PDO, Ka: Kasseri PDO, Sf: Sfela PDO, SM: San Mihali PDO, FAP: Formaella Arachovas Parnassou PDO, Ma: Manouri PDO, XK: Xinomizithra Kritis PDO.</p>
Full article ">Figure 5
<p>Flow-diagram presenting methodology for and the design and development of a branded food composition database (BFCD) for “quality label” foods.</p>
Full article ">
18 pages, 325 KiB  
Review
To Improve the Initial Inpatient Management of Adolescents Admitted with Severe Anorexia Nervosa: A Narrative Review and a Convenient Protocol
by Stephanie Proulx-Cabana, Marie-Elaine Metras, Danielle Taddeo, Olivier Jamoulle, Jean-Yves Frappier and Chantal Stheneur
Nutrients 2022, 14(1), 229; https://doi.org/10.3390/nu14010229 - 5 Jan 2022
Cited by 7 | Viewed by 5014
Abstract
Inadequate nutritional rehabilitation of severely malnourished adolescents with Anorexia Nervosa (AN) increases the risk of medical complications. There is no consensus on best practices for inpatient nutritional rehabilitation and medical stabilization for severe AN. This study aimed to elaborate an admission protocol for [...] Read more.
Inadequate nutritional rehabilitation of severely malnourished adolescents with Anorexia Nervosa (AN) increases the risk of medical complications. There is no consensus on best practices for inpatient nutritional rehabilitation and medical stabilization for severe AN. This study aimed to elaborate an admission protocol for adolescents with severe AN based on a comprehensive narrative review of current evidence. A Pubmed search was conducted in July 2017 and updated in August 2020, using the keywords severe AN or eating disorders (ED), management guidelines and adolescent. Relevant references cited in these guidelines were retrieved. A secondary search was conducted using AN or ED and refeeding protocol, refeeding syndrome (RS), hypophosphatemia, hypoglycemia, cardiac monitoring or cardiac complications. Evidence obtained was used to develop the admission protocol. Selective blood tests were proposed during the first three days of nutritional rehabilitation. Higher initial caloric intake is supported by evidence. Continuous nasogastric tube feeding was proposed for patients with a BMI < 12 kg/m2. We monitor hypoglycemia for 72 h. Continuous cardiac monitoring for bradycardia <30 BPM and systematic phosphate supplementation should be considered. Developing protocols is necessary to improve standardization of care. We provide an example of an inpatient admission protocol for adolescents with severe AN. Full article
(This article belongs to the Special Issue Nutritional Management and Outcomes in Anorexia Nervosa)
13 pages, 1245 KiB  
Article
Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial
by Anxo Fernández-Ferreiro, Francisco J. Formigo-Couceiro, Roi Veiga-Gutierrez, Jose A. Maldonado-Lobón, Ana M. Hermida-Cao, Carlos Rodriguez, Oscar Bañuelos, Mónica Olivares and Ruth Blanco-Rojo
Nutrients 2022, 14(1), 228; https://doi.org/10.3390/nu14010228 - 5 Jan 2022
Cited by 27 | Viewed by 5739
Abstract
Elderly people are particularly vulnerable to COVID-19, with a high risk of developing severe disease and a reduced immune response to the COVID-19 vaccine. A randomized, placebo-controlled, double-blind trial to assess the effect of the consumption of the probiotic Loigolactobacillus coryniformis K8 CECT [...] Read more.
Elderly people are particularly vulnerable to COVID-19, with a high risk of developing severe disease and a reduced immune response to the COVID-19 vaccine. A randomized, placebo-controlled, double-blind trial to assess the effect of the consumption of the probiotic Loigolactobacillus coryniformis K8 CECT 5711 on the immune response generated by the COVID-19 vaccine in an elderly population was performed. Two hundred nursing home residents >60 yrs that had not COVID-19 were randomized to receive L. coryniformis K8 or a placebo daily for 3 months. All volunteers received a complete vaccination schedule of a mRNA vaccine, starting the intervention ten days after the first dose. Specific IgG and IgA antibody levels were analyzed 56 days after the end of the immunization process. No differences between the groups were observed in the antibody levels. During the intervention, 19 subjects had COVID-19 (11 receiving K8 vs. 8 receiving placebo, p = 0.457). Subgroup analysis in these patients showed that levels of IgG were significantly higher in those receiving K8 compared to placebo (p = 0.038). Among subjects >85 yrs that did not get COVID-19, administration of K8 tended to increase the IgA levels (p = 0.082). The administration of K8 may enhance the specific immune response against COVID-19 and may improve the COVID-19 vaccine-specific responses in elderly populations. Full article
(This article belongs to the Special Issue Role of Lactobacillus and Probiotics in Human Health and Diseases)
Show Figures

Figure 1

Figure 1
<p>Flow chart of the study.</p>
Full article ">Figure 2
<p>Levels of SARS-CoV-2 S1 RBD IgG and IgA antibodies (represented in Log10 of U/mL) in (<b>A</b>) volunteers infected with SARS-COV-2 during intervention (<span class="html-italic">n</span> = 10 in the probiotic group, <span class="html-italic">n</span> = 6 in the control group) and (<b>B</b>) volunteers not infected with SARS-CoV-2 older than 85 years old (<span class="html-italic">n</span> = 40 in the probiotic group, <span class="html-italic">n</span> = 48 in the control group). Data are represented as mean (bars) and SE (vertical lines). <span class="html-italic">p</span> value indicated differences between probiotic group (dark grey bars) and control (light grey bars) groups (univariate models adjusted by age, sex, disease index, and time to Covid-19 symptom’s resolution in Covid-19-infected subjects and adjusted by sex, disease index, and glucocorticoids in uninfected subjects).</p>
Full article ">Figure 3
<p>Relationship between the levels of SARS-CoV-2 S1 RBD IgA (represented in Log10 of U/mL) and levels of TGF-β (represented in Log10 of pg/mL) by control group (light grey points) and probiotic group (dark grey points). <span class="html-italic">p</span> values indicated the statistical significance of the linear regression analysis by intervention group adjusted by age, sex, and disease index.</p>
Full article ">
16 pages, 4386 KiB  
Article
Protective Effect of Probiotics Isolated from Traditional Fermented Tea Leaves (Miang) from Northern Thailand and Role of Synbiotics in Ameliorating Experimental Ulcerative Colitis in Mice
by Napapan Kangwan, Sarawut Kongkarnka, Nitsara Boonkerd, Kridsada Unban, Kalidas Shetty and Chartchai Khanongnuch
Nutrients 2022, 14(1), 227; https://doi.org/10.3390/nu14010227 - 5 Jan 2022
Cited by 21 | Viewed by 4170
Abstract
This study aimed to investigate the protective effect of probiotics and synbiotics from traditional Thai fermented tea leaves (Miang) on dextran sulfate sodium (DSS)-induced colitis in mice, in comparison to sulfasalazine. C57BL/6 mice were treated with probiotics L. pentosus A14-6, CMY46 and synbiotics, [...] Read more.
This study aimed to investigate the protective effect of probiotics and synbiotics from traditional Thai fermented tea leaves (Miang) on dextran sulfate sodium (DSS)-induced colitis in mice, in comparison to sulfasalazine. C57BL/6 mice were treated with probiotics L. pentosus A14-6, CMY46 and synbiotics, L. pentosus A14-6 combined with XOS, and L. pentosus CMY46 combined with GOS for 21 days. Colitis was induced with 2% DSS administration for seven days during the last seven days of the experimental period. The positive group was treated with sulfasalazine. At the end of the experiment, clinical symptoms, pathohistological changes, intestinal barrier integrity, and inflammatory markers were analyzed. The probiotics and synbiotics from Miang ameliorated DSS-induced colitis by protecting body weight loss, decreasing disease activity index, restoring the colon length, and reducing pathohistological damages. Furthermore, treatment with probiotics and synbiotics improved intestinal barrier integrity, accompanied by lowing colonic and systemic inflammation. In addition, synbiotics CMY46 combined with GOS remarkedly elevated the expression of IL-10. These results suggested that synbiotics isolated from Miang had more effectiveness than sulfasalazine. Thereby, they could represent a novel potential natural agent against colonic inflammation. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic experimental protocol for investigating the protective effect of probiotics and synbiotics from Miang on experimental colitis in mice. DSS, dextran sulfate sodium; XOS, xylooligosaccharides; GOS, galactooligosaccharides; sulfa, sulfasalazine. PBS, phosphate-buffered saline.</p>
Full article ">Figure 2
<p>The effects of probiotics and synbiotics on clinical symptoms and severity of colitis induced by DSS. (<b>a</b>) The body weight; (<b>b</b>) DAI; (<b>c</b>) weight loss score; (<b>d</b>) stool consistency score; (<b>e</b>) fecal bleeding score; (<b>f</b>) representative macroscopic images of colons from each mice group; (<b>g</b>) colon length; (<b>h</b>) spleen weight. Data expressed as mean ± SEM (<span class="html-italic">n</span> = 7). * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01 vs. normal group. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. DSS group.</p>
Full article ">Figure 3
<p>The effect of probiotics and synbiotics on DSS-induced histopathological damage in the colon. Histological images of distal colonic tissues stained with H and E in each experimental group and histopathological index was analyzed under light microscopy. The samples were observed at ×100 magnification. Data expressed as mean ± SEM (<span class="html-italic">n</span> = 7), ** <span class="html-italic">p</span> &lt; 0.01 vs. normal group. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. DSS group.</p>
Full article ">Figure 4
<p>The effect of probiotics and synbiotics from Miang on mucus-secreting goblet cells. PAS staining of mucosal glycoproteins in goblet cells in the apical epithelial cells was observed with intense magenta color in the apical epithelial cells. PAS staining score was analyzed using light microscopy (×200 magnification) from at least five fields. Data are expressed as mean ± SEM (<span class="html-italic">n</span> = 7), ** <span class="html-italic">p</span> &lt; 0.01 vs. normal group. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. DSS group.</p>
Full article ">Figure 5
<p>The effect of probiotics and synbiotics from Miang on colonic barrier integrity. (<b>a</b>) The expression of ZO-1; (<b>b</b>) occludin; (<b>c</b>) claudin-1; and (<b>d</b>) MUC-1 in the colon were detected by qRT-PCR analysis. Data are expressed as mean ± SEM (<span class="html-italic">n</span> = 7), * <span class="html-italic">p</span> &lt; 0.05 vs. normal group. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. DSS group.</p>
Full article ">Figure 6
<p>The effect of probiotics and synbiotics from Miang suppressed DSS-induced colonic inflammation. The expression levels of (<b>a</b>)TNF-α; (<b>b</b>) IL-1β; (<b>c</b>) IL-6; (<b>d</b>) COX-2; and (<b>e</b>) IL-10. Data expressed as mean ± SEM (<span class="html-italic">n</span> = 7), * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01 vs. normal group. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. DSS group.</p>
Full article ">Figure 7
<p>The effects of probiotics and synbiotics from Miang on DSS-induced systemic inflammation. The serum levels of (<b>a</b>)TNF-α; (<b>b</b>) IL-1β; (<b>c</b>) IL-6. Data are expressed as mean ± SEM (<span class="html-italic">n</span> = 4), ** <span class="html-italic">p</span> &lt; 0.01 vs. normal group. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. DSS group.</p>
Full article ">Figure 8
<p>The proposed model represents the protective effect of probiotics and synbiotics on ameliorating intestinal inflammation induced by DSS in mice. DSS, dextran sulfate sodium; DAI, disease activity index; ZO-1, zonula occludin-1; MUC-1, mucin 1; PAS, periodic acid Schiff; TNF- α, tumor necrosis factor-α; IL-1β, interleukin 1β; IL-6, interleukin 6; IL-10, interleukin 10; COX-2, cyclooxygenase 2.</p>
Full article ">
13 pages, 1406 KiB  
Article
Serum Leptin Levels, Nutritional Status, and the Risk of Healthcare-Associated Infections in Hospitalized Older Adults
by Elena Paillaud, Johanne Poisson, Clemence Granier, Antonin Ginguay, Anne Plonquet, Catherine Conti, Amaury Broussier, Agathe Raynaud-Simon and Sylvie Bastuji-Garin
Nutrients 2022, 14(1), 226; https://doi.org/10.3390/nu14010226 - 5 Jan 2022
Cited by 5 | Viewed by 2719
Abstract
We aimed to determine whether serum leptin levels are predictive of the occurrence of healthcare-associated infections (HAIs) in hospitalized older patients. In a prospective cohort, 232 patients had available data for leptin and were monitored for HAIs for 3 months. Admission data included [...] Read more.
We aimed to determine whether serum leptin levels are predictive of the occurrence of healthcare-associated infections (HAIs) in hospitalized older patients. In a prospective cohort, 232 patients had available data for leptin and were monitored for HAIs for 3 months. Admission data included comorbidities, invasive procedures, the Mini Nutritional Assessment (MNA), BMI, leptin, albumin and C-reactive protein levels, and CD4 and CD8 T-cell counts. Multivariate logistic regression modelling was used to identify predictors of HAIs. Of the 232 patients (median age: 84.8; females: 72.4%), 89 (38.4%) experienced HAIs. The leptin level was associated with the BMI (p < 0.0001) and MNA (p < 0.0001) categories. Women who experienced HAIs had significantly lower leptin levels than those who did not (5.9 μg/L (2.6–17.7) and 11.8 (4.6–26.3), respectively; p = 0.01; odds ratio (OR) (95% confidence interval): 0.67 (0.49–0.90)); no such association was observed for men. In a multivariate analysis of the women, a lower leptin level was significantly associated with HAIs (OR = 0.70 (0.49–0.97)), independently of comorbidities, invasive medical procedures, and immune status. However, leptin was not significantly associated with HAIs after adjustments for malnutrition (p = 0.26) or albuminemia (p = 0.15)—suggesting that in older women, the association between serum leptin levels and subsequent HAIs is mediated by nutritional status. Full article
Show Figures

Figure 1

Figure 1
<p>Adjustments for the ADL and CIRS-G scores; invasive procedures; serum CRP; serum albumin; the CD4/CD8 ratio; and the naïve CD8 T-cell, memory CD8 T-cell and effectors CD8 T-cell counts did not substantially change the relationship between the leptin level and the occurrence of HAIs.</p>
Full article ">
16 pages, 3351 KiB  
Systematic Review
Can Feeding a Millet-Based Diet Improve the Growth of Children?—A Systematic Review and Meta-Analysis
by Seetha Anitha, David Ian Givens, Kowsalya Subramaniam, Shweta Upadhyay, Joanna Kane-Potaka, Yakima D. Vogtschmidt, Rosemary Botha, Takuji W. Tsusaka, Swamikannu Nedumaran, Hemalatha Rajkumar, Ananthan Rajendran, Devraj J. Parasannanavar, Mani Vetriventhan and Raj Kumar Bhandari
Nutrients 2022, 14(1), 225; https://doi.org/10.3390/nu14010225 - 5 Jan 2022
Cited by 25 | Viewed by 9634
Abstract
Undernutrition, such as stunting and underweight, is a major public health concern, which requires multi-sectoral attention. Diet plays a key role in growth and should optimally supply all required nutrients to support the growth. While millets (defined broadly to include sorghum) are traditional [...] Read more.
Undernutrition, such as stunting and underweight, is a major public health concern, which requires multi-sectoral attention. Diet plays a key role in growth and should optimally supply all required nutrients to support the growth. While millets (defined broadly to include sorghum) are traditional foods, and climate smart nutritious crops, which are grown across Africa and Asia, they have not been mainstreamed like rice, wheat, and maize. Diversifying staples with millets can potentially provide more macro and micro nutrients, compared to the mainstream crops. However, there is little known scientific evidence to prove millets’ efficacy on growth. Therefore, a systematic review and meta-analysis was conducted to collate evidence of the benefits of millets in improving the growth of children. Eight eligible randomized feeding trials were included in the meta-analysis. Results from the randomized effect model showed a significant effect (p < 0.05) of millet-based diets on mean height (+28.2%) (n = 8), weight (n = 9) (+26%), mid upper arm circumference (n = 5) (+39%) and chest circumference (n = 5) (+37%) in comparison to regular rice-based diets over for the period of 3 months to 4.5 years, which was based on largely substituting rice with millets. When an enhanced and diverse diet was served, replacing rice with millet had only minimal growth improvement on chest circumference (p < 0.05). The quality assessment using GRADE shows that the evidence used for this systematic review and meta-analysis had moderate quality, based on eight scoring criteria. These results demonstrate the value of adding millet as the staple for undernourished communities. Further understanding of the efficacy of millets on growth in a wider range of diets is important to develop appropriate dietary programs and improve the nutritional status of various age groups across Africa and Asia. Full article
(This article belongs to the Section Pediatric Nutrition)
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram for the systematic review.</p>
Full article ">Figure 2
<p>Effect of consuming a millet-based diet on mean height change compared to a regular rice-based diet.</p>
Full article ">Figure 3
<p>Effect of consuming a millet-based diet on mean weight change compared to a regular rice-based diet.</p>
Full article ">Figure 4
<p>Effect of a consuming finger millet-based diet on mean change in MUAC compared to a regular rice-based diet.</p>
Full article ">Figure 5
<p>Effect of consuming a finger millet-based diet on mean change in chest circumference compared to a regular rice-based diet.</p>
Full article ">Figure 6
<p>Effect of consuming an enhanced diverse millet-based diet on mean height change compared to an enhanced diverse rice-based diet.</p>
Full article ">Figure 7
<p>Effect of consuming an enhanced diverse millet-based diet on mean weight change compared to an enhanced diverse rice-based diet.</p>
Full article ">Figure 8
<p>Effect of consuming an enhanced diverse millet-based diet on mean MUAC change compared to an enhanced diverse rice-based diet.</p>
Full article ">Figure 9
<p>Effect of consuming an enhanced diverse millet-based diet on mean chest circumference change compared to an enhanced diverse rice-based diet.</p>
Full article ">
35 pages, 676 KiB  
Review
Iron Status, Anemia, and Iron Interventions and Their Associations with Cognitive and Academic Performance in Adolescents: A Systematic Review
by Kaitlyn L. I. Samson, Jordie A. J. Fischer and Marion L. Roche
Nutrients 2022, 14(1), 224; https://doi.org/10.3390/nu14010224 - 5 Jan 2022
Cited by 42 | Viewed by 13595
Abstract
In adolescents, iron-deficiency anemia is the leading cause of disability-adjusted life years lost. The World Health Organization recommends delivering iron supplementation through school-based platforms, requiring partnerships with the education sector. This anemia-reduction intervention is valued for the perceived benefits of improved learning and [...] Read more.
In adolescents, iron-deficiency anemia is the leading cause of disability-adjusted life years lost. The World Health Organization recommends delivering iron supplementation through school-based platforms, requiring partnerships with the education sector. This anemia-reduction intervention is valued for the perceived benefits of improved learning and school performance. This article aims to systematically review the available evidence on the relationship between iron status and anemia and impacts of iron interventions on cognitive and academic performance in adolescents. Fifty studies were included: n = 26 cross-sectional and n = 24 iron-containing interventions. Our review suggests that iron status and anemia may be associated with academic performance in some contexts and that iron supplementation during adolescence may improve school performance, attention, and concentration. However, nearly all supplementation trials were judged to have moderate or high risk of bias. We did not find evidence suggesting that iron status and anemia influenced or were associated with attention, intelligence, nor memory in adolescents. Further, iron supplementation did not improve memory and recall or intelligence. Overall, more high-quality research is needed to guide programmers and policy makers to understand the relationships between anemia and educational performance and the potential impacts of iron interventions, which effectively reduce anemia, on adolescents’ learning and school performance. Full article
(This article belongs to the Special Issue Health Benefits of Iron and Folic Acid Supplementation)
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram of study selection.</p>
Full article ">
13 pages, 691 KiB  
Article
Predictors of Post-Exercise Energy Intake in Adolescents Ranging in Weight Status from Overweight to Severe Obesity
by Nicole Fearnbach, Amanda E. Staiano, Neil M. Johannsen, Daniel S. Hsia, Robbie A. Beyl, Owen T. Carmichael and Corby K. Martin
Nutrients 2022, 14(1), 223; https://doi.org/10.3390/nu14010223 - 5 Jan 2022
Cited by 1 | Viewed by 3122
Abstract
Exercise may sensitize individuals with overweight and obesity to appetitive signals (e.g., hunger and fullness cues), overriding trait eating behaviors that contribute to overeating and obesity, such as uncontrolled eating. The objective of the current study was to measure predictors of objective ad [...] Read more.
Exercise may sensitize individuals with overweight and obesity to appetitive signals (e.g., hunger and fullness cues), overriding trait eating behaviors that contribute to overeating and obesity, such as uncontrolled eating. The objective of the current study was to measure predictors of objective ad libitum energy intake at a laboratory-based, post-exercise test-meal in adolescents ranging in weight status from overweight to severe obesity. We hypothesized that appetitive states, rather than appetitive traits, would be the strongest predictors of energy intake at a post-exercise test-meal, after controlling for body size. At Baseline, 30 adolescents (ages 10–16 years, 50% female (F), 43% non-Hispanic white (NHW), 83% with obesity (OB)) completed state and trait appetite measures and an ad libitum dinner meal following intensive exercise. Nineteen of those participants (47% F, 32% NHW, 79% OB) completed identical assessments two years later (Year 2). Energy intake (kcal) at each time point was adjusted for fat-free mass index (i.e., body size). Adjusted energy intake was reliable from Baseline to Year 2 (ICC = 0.84). Multiple pre-meal appetite ratings were associated with test-meal energy intake. In stepwise linear regression models, pre-meal prospective food consumption was the strongest and only significant predictor of test-meal energy intake at both Baseline (R2 = 0.25, p = 0.005) and Year 2 (R2 = 0.41, p = 0.003). Baseline post-exercise energy intake was associated with weight change over two years (R2 = 0.24, p = 0.04), but not with change in fat mass (p = 0.11). Appetitive traits were not associated with weight or body composition change (p > 0.22). State appetite cues were the strongest predictors of post-exercise energy intake, independent of body size. Future studies should examine whether long-term exercise programs enhance responsiveness to homeostatic appetite signals in youth with overweight and obesity, with a goal to reduce excess energy intake and risk for weight gain over time. Full article
Show Figures

Figure 1

Figure 1
<p>Timeline of study assessments. Visit procedures were identical at Baseline and Year 2. Abbreviations: visual analog scales, VAS; Three-Factor Eating Questionnaire, TFEQ.</p>
Full article ">Figure 2
<p>Association between energy intake (adj. for FFMI) at Baseline and Year 2 (ICC = 0.84), depicted against a line of identity (solid line). Abbreviations: energy intake, EI; fat-free mass index, FFMI; intra-class correlation, ICC; baseline, Y0; year 2, Y2.</p>
Full article ">Figure 3
<p>Association between energy intake (adj. for FFMI) at Baseline and weight change (kg) from Baseline to Year 2 (r = 0.49, <span class="html-italic">p</span> = 0.04). Abbreviations: energy intake, EI; fat-free mass index, FFMI; baseline, Y0.</p>
Full article ">
12 pages, 941 KiB  
Article
Postoperative Dietary Intake Achievement: A Secondary Analysis of a Randomized Controlled Trial
by Chiou Yi Ho, Zuriati Ibrahim, Zalina Abu Zaid, Zulfitri Azuan Mat Daud, Nor Baizura Mohd Yusop, Mohd Norazam Mohd Abas and Jamil Omar
Nutrients 2022, 14(1), 222; https://doi.org/10.3390/nu14010222 - 5 Jan 2022
Cited by 5 | Viewed by 3916
Abstract
Sufficient postoperative dietary intake is crucial for ensuring a better surgical outcome. This study aimed to investigate the postoperative dietary intake achievement and predictors of postoperative dietary intake among gynecologic cancer patients. A total of 118 participants were included in this secondary analysis. [...] Read more.
Sufficient postoperative dietary intake is crucial for ensuring a better surgical outcome. This study aimed to investigate the postoperative dietary intake achievement and predictors of postoperative dietary intake among gynecologic cancer patients. A total of 118 participants were included in this secondary analysis. Postoperative dietary data was pooled and re-classified into early postoperative dietary intake achievement (EDIA) (daily energy intake (DEI) ≥ 75% from the estimated energy requirement (EER)) and delay dietary intake achievement (DDIA) (DEI < 75% EER) There was a significant difference in postoperative changes in weight (p = 0.002), muscle mass (p = 0.018), and handgrip strength (p = 0.010) between the groups. Postoperative daily energy and protein intake in the EDIA was significantly greater than DDIA from operation day to discharged (p = 0.000 and p = 0.036). Four significant independent postoperative dietary intake predictors were found: preoperative whey protein-infused carbohydrate loading (p = 0.000), postoperative nausea vomiting (p = 0.001), age (p = 0.010), and time to tolerate clear fluid (p = 0.016). The multilinear regression model significantly predicted postoperative dietary intake, F (4, 116) = 68.013, p = 0.000, adj. R2 = 0.698. With the four predictors’ recognition, the integration of a more specific and comprehensive dietitian-led supportive care with individualized nutrition intervention ought to be considered to promote functional recovery. Full article
(This article belongs to the Special Issue The Role of Perioperative Nutrition Support in Postoperative Recovery)
Show Figures

Figure 1

Figure 1
<p>Flow Diagram of the Subjects’ Selection Process and Specific Reasons for Exclusion.</p>
Full article ">Figure 2
<p>Postoperative total daily energy intake trend.</p>
Full article ">Figure 3
<p>Postoperative total daily protein intake trend.</p>
Full article ">
16 pages, 1583 KiB  
Article
A Cross-Sectional Reproducibility Study of a Standard Camera Sensor Using Artificial Intelligence to Assess Food Items: The FoodIntech Project
by Virginie Van Wymelbeke-Delannoy, Charles Juhel, Hugo Bole, Amadou-Khalilou Sow, Charline Guyot, Farah Belbaghdadi, Olivier Brousse and Michel Paindavoine
Nutrients 2022, 14(1), 221; https://doi.org/10.3390/nu14010221 - 5 Jan 2022
Cited by 7 | Viewed by 3679
Abstract
Having a system to measure food consumption is important to establish whether individual nutritional needs are being met in order to act quickly and to minimize the risk of undernutrition. Here, we tested a smartphone-based food consumption assessment system named FoodIntech. FoodIntech, which [...] Read more.
Having a system to measure food consumption is important to establish whether individual nutritional needs are being met in order to act quickly and to minimize the risk of undernutrition. Here, we tested a smartphone-based food consumption assessment system named FoodIntech. FoodIntech, which is based on AI using deep neural networks (DNN), automatically recognizes food items and dishes and calculates food leftovers using an image-based approach, i.e., it does not require human intervention to assess food consumption. This method uses one-input and one-output images by means of the detection and synchronization of a QRcode located on the meal tray. The DNN are then used to process the images and implement food detection, segmentation and recognition. Overall, 22,544 situations analyzed from 149 dishes were used to test the reliability of this method. The reliability of the AI results, based on the central intra-class correlation coefficient values, appeared to be excellent for 39% of the dishes (n = 58 dishes) and good for 19% (n = 28). The implementation of this method is an effective way to improve the recognition of dishes and it is possible, with a sufficient number of photos, to extend the capabilities of the tool to new dishes and foods. Full article
(This article belongs to the Section Clinical Nutrition)
Show Figures

Figure 1

Figure 1
<p>Food segmentation example applied to (<b>a</b>) plate with food served, (<b>b</b>) segmentation of each food of the plate.</p>
Full article ">Figure 2
<p>Implementing computer vision technology and a deep learning process to recognize food items and calculate the amount of missing food between two meal tray pictures.</p>
Full article ">Figure 3
<p>Meal trays with QRCode label (<b>a</b>) before consumption and (<b>b</b>) after consumption.</p>
Full article ">Figure 4
<p>Flow chart of the design.</p>
Full article ">
13 pages, 2627 KiB  
Article
Saffron (Crocus sativus L.) Flower Water Extract Disrupts the Cecal Microbiome, Brush Border Membrane Functionality, and Morphology In Vivo (Gallus gallus)
by Nikita Agarwal, Nikolai Kolba, YeonJin Jung, Jacquelyn Cheng and Elad Tako
Nutrients 2022, 14(1), 220; https://doi.org/10.3390/nu14010220 - 5 Jan 2022
Cited by 17 | Viewed by 4588
Abstract
Saffron (Crocus sativus L.) is known as the most expensive spice. C. sativus dried red stigmas, called threads, are used for culinary, cosmetic, and medicinal purposes. The rest of the flower is often discarded, but is now being used in teas, as [...] Read more.
Saffron (Crocus sativus L.) is known as the most expensive spice. C. sativus dried red stigmas, called threads, are used for culinary, cosmetic, and medicinal purposes. The rest of the flower is often discarded, but is now being used in teas, as coloring agents, and fodder. Previous studies have attributed antioxidant, anti-inflammatory, hepatoprotective, neuroprotective, anti-depressant, and anticancer properties to C. sativus floral bio-residues. The aim of this study is to assess C. sativus flower water extract (CFWE) for its effects on hemoglobin, brush boarder membrane (BBM) functionality, morphology, intestinal gene expression, and cecal microbiome in vivo (Gallus gallus), a clinically validated model. For this, Gallus gallus eggs were divided into six treatment groups (non-injected, 18 Ω H2O, 1% CFWE, 2% CFWE, 5% CFWE, and 10% CFWE) with n~10 for each group. On day 17 of incubation, 1 mL of the extracts/control were administered in the amnion of the eggs. The amniotic fluid along with the administered extracts are orally consumed by the developing embryo over the course of the next few days. On day 21, the hatchlings were euthanized, the blood, duodenum, and cecum were harvested for assessment. The results showed a significant dose-dependent decrease in hemoglobin concentration, villus surface area, goblet cell number, and diameter. Furthermore, we observed a significant increase in Paneth cell number and Mucin 2 (MUC2) gene expression proportional to the increase in CFWE concentration. Additionally, the cecum microbiome analysis revealed C. sativus flower water extract altered the bacterial populations. There was a significant dose-dependent reduction in Lactobacillus and Clostridium sp., suggesting an antibacterial effect of the extract on the gut in the given model. These results suggest that the dietary consumption of C. sativus flower may have negative effects on BBM functionality, morphology, mineral absorption, microbial populations, and iron status. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Effect of the intra-amniotic administration of increasing concentration of CFWE and controls on duodenal gene expression. Values are the means (AU: arbitrary units) ± SEM, <span class="html-italic">n</span> = 6. <sup>a, b, c</sup> genes (column wise) not indicated by the same letter are significantly different (<span class="html-italic">p</span> &lt; 0.05). Dcytb, duodenal cytochrome b; DMT1, divalent metal transporter 1; ZIP1, Zrt-, Irt-like proteins; ZnT1, zinc transporter 1; NF-κβ, nuclear factor kappa beta; TNF-α, tumor necrosis factor; IL8, interleukin 8; SGLT1, sodium-glucose cotransporter 1; SI, sucrose isomaltase; MUC2, mucin 2.</p>
Full article ">Figure 2
<p>Cross-section of the duodenum (<span class="html-italic">Gallus gallus</span>). (<b>A</b>) Points out a Paneth cell that is stained light purple. (<b>B</b>) Represents a neutral goblet cell, stained light purple. (<b>C</b>) Points to an acidic goblet cell, stained bright blue. Stain used: AB/PAS.</p>
Full article ">Figure 3
<p>Heatmap showing the effect of different concentrations of dietary CFWE supplementation compared with controls on the populations of <span class="html-italic">Lactobacillus</span>, <span class="html-italic">Clostridium</span>, <span class="html-italic">Escherichia coli</span>, and <span class="html-italic">Bifidobacterium</span> in <span class="html-italic">Gallus gallus</span> cecum. The relative abundance is expressed in arbitrary units (AU). Values are the means ± SEM, <span class="html-italic">n</span> = 5. <sup>a–c</sup> groups not indicated by the same letter are significantly different (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
9 pages, 2023 KiB  
Communication
High Hydrostatic Pressure Processing of Human Milk Increases Apelin and GLP-1 Contents to Modulate Gut Contraction and Glucose Metabolism in Mice Compared to Holder Pasteurization
by Eve Wemelle, Lucie Marousez, Marie de Lamballerie, Claude Knauf and Jean Lesage
Nutrients 2022, 14(1), 219; https://doi.org/10.3390/nu14010219 - 5 Jan 2022
Cited by 5 | Viewed by 2622
Abstract
Background: High hydrostatic pressure (HHP) processing is a non-thermal method proposed as an alternative to Holder pasteurization (HoP) for the sterilization of human breast milk (BM). HHP preserves numerous milk bioactive factors that are degraded by HoP, but no data are available for [...] Read more.
Background: High hydrostatic pressure (HHP) processing is a non-thermal method proposed as an alternative to Holder pasteurization (HoP) for the sterilization of human breast milk (BM). HHP preserves numerous milk bioactive factors that are degraded by HoP, but no data are available for milk apelin and glucagon-like peptide 1 (GLP-1), two hormones implicated in the control of glucose metabolism directly and via the gut–brain axis. This study aims to determine the effects of HoP and HHP processing on apelin and GLP-1 concentrations in BM and to test the effect of oral treatments with HoP- and HHP-BM on intestinal contractions and glucose metabolism in adult mice. Methods: Mice were treated by daily oral gavages with HoP- or HHP-BM during one week before intestinal contractions, and glucose tolerance was assessed. mRNA expression of enteric neuronal enzymes known to control intestinal contraction was measured. Results: HoP-BM displayed a reduced concentration of apelin and GLP-1, whereas HHP processing preserved these hormones close to their initial levels in raw milk. Chronic HHP-BM administration to mice increased ileal mRNA nNos expression level leading to a decrease in gut contraction associated with improved glucose tolerance. Conclusion: In comparison to HoP, HPP processing of BM preserves both apelin and GLP-1 and improves glucose tolerance by acting on gut contractions. This study reinforces previous findings demonstrating that HHP processing provides BM with a higher biological value than BM treated by HoP. Full article
(This article belongs to the Special Issue Feeding in Preterm Infants)
Show Figures

Figure 1

Figure 1
<p>Concentrations of apelin (<b>A</b>) and GLP-1 (<b>B</b>) in raw human milk (RM) and after Holder pasteurization (HoP) and high hydrostatic pressure (HHP) processing of BM. Data are presented as mean ± SEM. Asterisks correspond to level of statistical significance: * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 2
<p>HHP-BM decreases duodenal contraction amplitude. Ex vivo measurement of duodenum (<b>A</b>), jejunum (<b>B</b>), ileum (<b>C</b>) and colon (<b>D</b>) mechanical contraction amplitude and frequency in response to HoP- or HHP-BM added in the medium (100 µL, <span class="html-italic">n</span> = 7–8). Results are expressed as a percentage of the basal contractions amplitude or frequency. * <span class="html-italic">p</span> &lt; 0.05 compared to HoP-BM.</p>
Full article ">Figure 3
<p>A chronic oral HHP-BM treatment improves glucose tolerance in adult mice. Oral Glucose Tolerance Test (OGTT) in fasted mice after an oral administration of HoP- or HHP-BM (100 µL/day during one week; <span class="html-italic">n</span> = 9 per group). (<b>A</b>) Fasted glycemia, (<b>B</b>) Glycemia during OGTT and the area under the curve (AUC) (<b>C</b>) and HOMA index (<b>D</b>), plasma insulin (<b>E</b>) and glucagon levels (<b>F</b>). * <span class="html-italic">p</span> &lt; 0.05 compared to mice treated with HoP-BM.</p>
Full article ">Figure 4
<p>Chronic oral HHP milk treatment decreases ileal contraction amplitude. Ex vivo measurement of duodenum (<b>A</b>), jejunum (<b>B</b>), ileum (<b>C</b>) and colon (<b>D</b>) mechanical contraction amplitude and frequency in response to chronic oral treatment with HoP- or HHP-BM (100 µL/day during one week; <span class="html-italic">n</span> = 8–10 per group). Expression of <span class="html-italic">nNos</span> and <span class="html-italic">Chat</span> mRNAs in the duodenum (<span class="html-italic">n</span> = 9) (<b>E</b>) and in the ileum (<b>F</b>). * <span class="html-italic">p</span> &lt; 0.05 compared to HoP-BM treated mice.</p>
Full article ">Figure 4 Cont.
<p>Chronic oral HHP milk treatment decreases ileal contraction amplitude. Ex vivo measurement of duodenum (<b>A</b>), jejunum (<b>B</b>), ileum (<b>C</b>) and colon (<b>D</b>) mechanical contraction amplitude and frequency in response to chronic oral treatment with HoP- or HHP-BM (100 µL/day during one week; <span class="html-italic">n</span> = 8–10 per group). Expression of <span class="html-italic">nNos</span> and <span class="html-italic">Chat</span> mRNAs in the duodenum (<span class="html-italic">n</span> = 9) (<b>E</b>) and in the ileum (<b>F</b>). * <span class="html-italic">p</span> &lt; 0.05 compared to HoP-BM treated mice.</p>
Full article ">
14 pages, 2001 KiB  
Article
Anxiolytic Effect and Improved Sleep Quality in Individuals Taking Lippia citriodora Extract
by Alejandro Martínez-Rodríguez, María Martínez-Olcina, Juan Mora, Pau Navarro, Nuria Caturla and Jonathan Jones
Nutrients 2022, 14(1), 218; https://doi.org/10.3390/nu14010218 - 4 Jan 2022
Cited by 9 | Viewed by 7022
Abstract
The current fast-moving, hectic lifestyle has increased the number of individuals worldwide with difficulties in managing stress, which in turn is also affecting their sleep quality. Therefore, the objective of the current study was to assess a natural plant-based dietary supplement comprised of [...] Read more.
The current fast-moving, hectic lifestyle has increased the number of individuals worldwide with difficulties in managing stress, which in turn is also affecting their sleep quality. Therefore, the objective of the current study was to assess a natural plant-based dietary supplement comprised of lemon verbena (Lippia citriodora) extract, purified in phenylpropanoids, in alleviating stress and improving quality of sleep. A double-blind, placebo-controlled study was conducted for 8 weeks, followed by a 4-week washout period. Both validated questionnaires and functional tests were performed during the study, whereas questionnaires were used after the washout. As a result, the group taking the lemon verbena extract significantly reduced their perception of stress after 8 weeks, which was corroborated by a significant decrease in cortisol levels. After the washout period, the subjects reported to present even lower stress levels, due to the lasting effect of the ingredient. As for sleep quality, the subjects taking the supplement reported feeling better rested, with a stronger effect observed in women. Sleep tracking using a wearable device revealed that the supplement users improved their times in the deeper stages of sleep, specifically their percentage of time in deep sleep and REM. In conclusion, lemon verbena extract purified in phenylpropanoids is revealed as a natural solution to help individuals to improve their stress and sleep quality. Full article
(This article belongs to the Special Issue Diet and Sleep: The Towers of Lifestyle, Wellness, and Survival)
Show Figures

Figure 1

Figure 1
<p>Participant’s flowchart.</p>
Full article ">Figure 2
<p>Chromatogram of the lemon verbena extract used in the study, analyzed at 330 nm.</p>
Full article ">Figure 3
<p>Design and development of the intervention. PSS = perceived stress scale; PSQI = Pittsburgh sleep quality index.</p>
Full article ">Figure 4
<p>Development of the visits. PSS = perceived stress scale; PSQI = Pittsburgh sleep quality index.</p>
Full article ">
11 pages, 2280 KiB  
Article
IBF-R Regulates IRE1α Post-Translational Modifications and ER Stress in High-Fat Diet-Induced Obese Mice
by Hwa-Young Lee, Geum-Hwa Lee, Young Yoon, The-Hiep Hoang and Han-Jung Chae
Nutrients 2022, 14(1), 217; https://doi.org/10.3390/nu14010217 - 4 Jan 2022
Cited by 8 | Viewed by 3521
Abstract
Obesity is a global health issue linked to the heightened risk of several chronic diseases. Rhus verniciflua (RV) is a traditional food supplement used for a range of pharmacological effects such as antitumor, antioxidant, α-glucosidase inhibitory effects, hepatitis, and arthritis. Despite the traditional [...] Read more.
Obesity is a global health issue linked to the heightened risk of several chronic diseases. Rhus verniciflua (RV) is a traditional food supplement used for a range of pharmacological effects such as antitumor, antioxidant, α-glucosidase inhibitory effects, hepatitis, and arthritis. Despite the traditional medicinal values, scientific evidence for its application in obesity is inadequate and unclear. Thus, this investigation was designed to evaluate the anti-obesity effects of IBF-R, an RV extract, using a high-fat diet (HFD) model. The study has six groups: chow diet group; chow diet with 80 mg/kg IBF-R; HFD group; IBF-R group with 20, 40, and 80 mg/kg. IBF-R supplementation significantly regulated the weight gain than the HFD fed mice. Further, IBF-R supplementation lowered the expressions of adipogenic transcription factors such as SREBP-1c, C/EBPα, FAS, and PPAR-γ in white adipose tissue (WAT) of diet-induced obese mice. In addition, IBF-R supplementation reduced the lipogenic gene expression while enhancing genes was related to fatty acid oxidation. Obesity is linked to redox-based post-translational modifications (PTMs) of IRE1α such as S-nitrosylation, endoplasmic reticulum (ER) stress, and chronic metabolic inflammation. The administration of IBF-R inhibits these PTMs. Notably, IBF-R administration significantly enhanced the expression of AMPK and sirtuin 1 in WAT of HFD-fed mice. Together, these findings reveal the IRE1α S-nitrosylation-inflammation axis as a novel mechanism behind the positive implications of IBF-R on obesity. In addition, it lays a firm foundation for the development of Rhus verniciflua extract as a functional ingredient in the food and pharmaceutical industries. Full article
(This article belongs to the Section Nutrition and Obesity)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Influence of IBF-R on body weight and fat mass. Mice were fed with NCD or HFD with vehicle or IBF-R (20, 40, or 80 mg/kg). All the animals were gavaged daily for 12 weeks. (<b>a</b>) Variations in body weight at predetermined time points. (<b>b</b>) Representative images of HFD mice after 12 weeks of IBF-R supplementation. (<b>c</b>) Representative Micro-CT images were obtained using Skyscan1076 micro-CT scanner. (<b>d</b>) Quantification of fat mass with Skyscan1076 micro-CT scanner at the end of the experiment. (<b>e</b>–<b>g</b>) Measurement of epididymal white adipose tissue (eWAT), inguinal white adipose tissue (iWAT) and liver weight. Data are shown as mean ± SEM (<span class="html-italic">n</span> = 10, * <span class="html-italic">p</span> &lt; 0.05 vs. NCD + vehicle, # <span class="html-italic">p</span> &lt; 0.05 vs. HFD + vehicle).</p>
Full article ">Figure 2
<p>Influence of IBF-R serum biochemicals profile and lipid accumulation. Levels of triglyceride (<b>a</b>), total cholesterol (<b>b</b>), adiponectin (<b>c</b>), and leptin (<b>d</b>). (<b>e</b>) Representative images of liver sections stained with H&amp;E (upper) and Nile Red stain (lower). Scale bars = 50 µm. Data are shown as mean ± SEM (<span class="html-italic">n</span> = 10, * <span class="html-italic">p</span> &lt; 0.05 vs. NCD + vehicle, # <span class="html-italic">p</span> &lt; 0.05 vs. HFD + vehicle).</p>
Full article ">Figure 3
<p>IBF-R diminish ER stress and IRE1α S-nitrosylation of axis in HFD model. (<b>a</b>) Immunoblotting of p-IRE1α, IRE1α, GRP78, CHOP, sXBP-1, and β-actin expressions in eWAT. (<b>b</b>) Quantitative analysis of proteins. (<b>c</b>,<b>d</b>) sXBP1 expressions at the nuclear level from each group and quantitative analysis. (<b>e</b>) eWAT lysate was examined for PDI in HMWCs on non-reducing gels. (<b>f</b>) iNOS and eNOS mRNAs were measured in eWAT by qRT-PCR. (<b>g</b>) General S-nitrosylation (SNO) profile in eWAT of HFD mice and NCD controls. (<b>h</b>) Specific SNO proteins in the eWAT of HFD mice and NCD controls. S-nitrosylated proteins were purified with biotin-switch assay and detected by immunoblotting. Data are shown as mean ± SEM (<span class="html-italic">n</span> = 10, * <span class="html-italic">p</span> &lt; 0.05 vs. NCD + vehicle, # <span class="html-italic">p</span> &lt; 0.05 vs. HFD + vehicle). eWAT; epididymal white adipose tissue.</p>
Full article ">Figure 4
<p>IBF-R determines adipose tissue expansion and adipogenic factors in eWAT. (<b>a</b>) H&amp;E staining in eWAT. Scale bar = 50 µm. (<b>b</b>) The mean diameter of adipocytes in eWAT. (<b>c</b>–<b>f</b>) C/EBPα, PPAR-γ, FAS and SREBP-1c were measured in eWAT by qRT-PCR. (<b>g</b>) Immunoblotting of PPAR-γ, C/EBPα, SREBP-1c, FAS, and β-actin expressions in eWAT. (<b>h</b>–<b>k</b>) Quantification of protein expressions. (<b>l</b>,<b>m</b>) Immunoblotting of p-AMPK, AMPK, SIRT-1, and β-actin expressions in eWAT and respective quantitative analysis. Data are shown as mean ± SEM (<span class="html-italic">n</span> = 10, * <span class="html-italic">p</span> &lt; 0.05 vs. NCD + vehicle, # <span class="html-italic">p</span> &lt; 0.05 vs. HFD + vehicle). eWAT; epididymal white adipose tissue.</p>
Full article ">
12 pages, 789 KiB  
Article
Acceptability of Plant-Based Diets for People with Chronic Kidney Disease: Perspectives of Renal Dietitians
by Jordan Stanford, Mikaela Zuck, Anita Stefoska-Needham, Karen Charlton and Kelly Lambert
Nutrients 2022, 14(1), 216; https://doi.org/10.3390/nu14010216 - 4 Jan 2022
Cited by 5 | Viewed by 4607
Abstract
The purpose of this study was to explore the perspective of renal dietitians regarding plant-based diets for chronic kidney disease (CKD) management and evaluate the acceptability of a hypothetical plant-based dietary prescription aiming for the consumption of 30 unique plant foods per week. [...] Read more.
The purpose of this study was to explore the perspective of renal dietitians regarding plant-based diets for chronic kidney disease (CKD) management and evaluate the acceptability of a hypothetical plant-based dietary prescription aiming for the consumption of 30 unique plant foods per week. This study used an exploratory mixed methods design. Forty-six renal dietitians participated in either an online survey (n = 35) or an in-depth interview (n = 11). Dietitians perceived that plant-based diets could address multiple clinical concerns relevant to CKD. Forty percent of survey respondents reported the hypothetical dietary prescription was realistic for people with CKD, 34.3% were unsure, and 25.7% perceived it as unrealistic. Strengths of the hypothetical prescription included shifting the focus to whole foods and using practical resources like recipes. Limited staffing, time, and follow-up opportunities with patients, as well as differing nutrition philosophies were the most commonly reported challenges to implementation; while a supportive multidisciplinary team was identified as an important enabler. To increase patient acceptance of plant-based dietary approaches, education about plant food benefits was recommended, as was implementing small, incremental dietary changes. Successful implementation of plant-based diets is perceived to require frequent patient contact and ongoing education and support by a dietitian. Buy-in from the multidisciplinary team was also considered imperative. Full article
(This article belongs to the Special Issue Plant-Based Diets: Working towards a Sustainable Future)
Show Figures

Figure 1

Figure 1
<p>Summary of responses to multiple-choice survey questions. (<b>A</b>) Answers to whether the target of consuming 30 unique plant-based foods over seven days is realistic for patients with CKD. (<b>B</b>) Responses to the question about which plant foods dietitians felt cautious about prescribing to people with CKD. (<b>C</b>) Potential challenges to implementing plant-based diets for people with CKD. (<b>D</b>) Potential enablers to implementing plant-based diets for people with CKD. Multiple responses were accepted for the questions presented in figures (<b>B</b>–<b>D</b>).</p>
Full article ">
12 pages, 676 KiB  
Article
The Cost-Effectiveness of Supplemental Carnosine in Type 2 Diabetes
by Kirthi Menon, Barbora de Courten, Dianna J. Magliano, Zanfina Ademi, Danny Liew and Ella Zomer
Nutrients 2022, 14(1), 215; https://doi.org/10.3390/nu14010215 - 4 Jan 2022
Cited by 5 | Viewed by 3030
Abstract
In this paper, we assess the cost-effectiveness of 1 g daily of carnosine (an over the counter supplement) in addition to standard care for the management of type 2 diabetes and compare it to standard care alone. Dynamic multistate life table models were [...] Read more.
In this paper, we assess the cost-effectiveness of 1 g daily of carnosine (an over the counter supplement) in addition to standard care for the management of type 2 diabetes and compare it to standard care alone. Dynamic multistate life table models were constructed in order to estimate both clinical outcomes and costs of Australians aged 18 years and above with and without type 2 diabetes over a ten-year period, 2020 to 2029. The dynamic nature of the model allowed for population change over time (migration and deaths) and accounted for the development of new cases of diabetes. The three health states were ‘Alive without type 2 diabetes’, ‘Alive with type 2 diabetes’ and ‘Dead’. Transition probabilities, costs, and utilities were obtained from published sources. The main outcome of interest was the incremental cost-effectiveness ratio (ICER) in terms of cost per year of life saved (YoLS) and cost per quality-adjusted life year (QALY) gained. Over the ten-year period, the addition of carnosine to standard care treatment resulted in ICERs (discounted) of AUD 34,836 per YoLS and AUD 43,270 per QALY gained. Assuming the commonly accepted willingness to pay threshold of AUD 50,000 per QALY gained, supplemental dietary carnosine may be a cost-effective treatment option for people with type 2 diabetes in Australia. Full article
(This article belongs to the Section Nutrition and Diabetes)
Show Figures

Figure 1

Figure 1
<p>Illustration of the dynamic nature of the model which allows for movement between health states.</p>
Full article ">Figure 2
<p>The cost-effectiveness acceptability curve, demonstrating that 62.5% of iterations were below Australia’s commonly-accepted willingness to pay threshold of AUD 50,000 per QALY gained. Results are reported in 2020 Australian dollars (AUD).</p>
Full article ">
19 pages, 25186 KiB  
Article
Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity
by Lukasz Szczerbinski, Gladys Wojciechowska, Adam Olichwier, Mark A. Taylor, Urszula Puchta, Paulina Konopka, Adam Paszko, Anna Citko, Joanna Goscik, Oliver Fiehn, Sili Fan, Anna Wasilewska, Katarzyna Taranta-Janusz and Adam Kretowski
Nutrients 2022, 14(1), 214; https://doi.org/10.3390/nu14010214 - 4 Jan 2022
Cited by 24 | Viewed by 6139
Abstract
Obesity rates among children are growing rapidly worldwide, placing massive pressure on healthcare systems. Untargeted metabolomics can expand our understanding of the pathogenesis of obesity and elucidate mechanisms related to its symptoms. However, the metabolic signatures of obesity in children have not been [...] Read more.
Obesity rates among children are growing rapidly worldwide, placing massive pressure on healthcare systems. Untargeted metabolomics can expand our understanding of the pathogenesis of obesity and elucidate mechanisms related to its symptoms. However, the metabolic signatures of obesity in children have not been thoroughly investigated. Herein, we explored metabolites associated with obesity development in childhood. Untargeted metabolomic profiling was performed on fasting serum samples from 27 obese Caucasian children and adolescents and 15 sex- and age-matched normal-weight children. Three metabolomic assays were combined and yielded 726 unique identified metabolites: gas chromatography–mass spectrometry (GC–MS), hydrophilic interaction liquid chromatography coupled to mass spectrometry (HILIC LC–MS/MS), and lipidomics. Univariate and multivariate analyses showed clear discrimination between the untargeted metabolomes of obese and normal-weight children, with 162 significantly differentially expressed metabolites between groups. Children with obesity had higher concentrations of branch-chained amino acids and various lipid metabolites, including phosphatidylcholines, cholesteryl esters, triglycerides. Thus, an early manifestation of obesity pathogenesis and its metabolic consequences in the serum metabolome are correlated with altered lipid metabolism. Obesity metabolite patterns in the adult population were very similar to the metabolic signature of childhood obesity. Identified metabolites could be potential biomarkers and used to study obesity pathomechanisms. Full article
(This article belongs to the Special Issue Biomarkers of Nutritional Exposure and Nutritional Status)
Show Figures

Figure 1

Figure 1
<p>Volcano plot of metabolites across groups, with log-transformed adjusted <span class="html-italic">p</span>-values and fold changes. Red circles represent metabolites with increased expression in the obesity group. Blue circles represent metabolites with decreased expression in subjects with obesity. Grey circles represent non-significant metabolites (adjusted <span class="html-italic">p</span>-values ≥ 0.05). The top 15 top significant metabolites are labeled. SM, sphingomyelin; PC, phosphatidylcholine; CE, cholesteryl ester; TG, triacylglycerol; 9,10-EpOME, 9,10-epoxyoctadecenoic acid; PI, phosphatidylinositol.</p>
Full article ">Figure 2
<p>Metabolite classes with significantly different concentrations between patient groups.</p>
Full article ">Figure 3
<p>Box-plots of selected metabolites with significantly different concentrations between children with (green) and without (red) obesity. Fold changes and <span class="html-italic">p</span>-values are provided in <a href="#app1-nutrients-14-00214" class="html-app">Table S1</a>. (<b>A</b>) Sphingomyelin (SM) d36:1 (d18:1/18:0); (<b>B</b>) Phosphate; (<b>C</b>) Phosphatidylcholine (PC) 40:6 (18:1/22:5); (<b>D</b>) Cholesteryl eicosapentaenoic acid (CE (20:5); (<b>E</b>) Triacylglycerol (TG) 58:8; (<b>F</b>) 9,10-epoxyoctadecenoic acid (9,10-EpOME).</p>
Full article ">Figure 4
<p>Box-plots of BCAAs with significantly different concentrations between children with (green) and without (red) obesity. Fold changes and <span class="html-italic">p</span>-values are provided in <a href="#app1-nutrients-14-00214" class="html-app">Table S1</a>. (<b>A</b>) Leucine; (<b>B</b>) Isoleucine; (<b>C</b>) Valine.</p>
Full article ">Figure 5
<p>Univariate ROC curve results for phosphate and sphingomyelin SM (d18:1/18:0). (<b>A</b>,<b>B</b>) ROC curves for (<b>A</b>) phosphate (<b>A</b>) and (<b>B</b>) SM (d18:1/18:0). Sensitivity and specificity are shown on the y- and x-axes, respectively. The area-under-the-curve (AUC) is in blue, and 95% CIs are shown. (<b>C</b>,<b>D</b>) Box-plots of (<b>C</b>) phosphate and (<b>D</b>) SM (d18:1/18:0) between children with (green) and without (red) obesity. The red horizontal line represents the optimal cut-off.</p>
Full article ">Figure 6
<p>PCA analysis between patient groups. (<b>A</b>) Two-dimensional (2D) score plots between PC1 and PC2. Patients with obesity are shown in green, and those without obesity are shown in red. (<b>B</b>) Scree plot showing the variance explained by PCs 1−5.</p>
Full article ">Figure 7
<p>OPLS-DA analysis between patient groups. (<b>A</b>) Score plot of all metabolite features. (<b>B</b>) Permutation analysis with observed and cross-validated R2Y and Q2 coefficients. (<b>C</b>) Important metabolites identified by OPLS-DA. Colored boxes on the right indicate metabolite concentrations in each patient group. SM, sphingomyelin; PC, phosphatidylcholine; CE, cholesteryl ester; TG, triacylglycerol; 9,10-EpOME, 9,10-epoxyoctadecenoic acid.</p>
Full article ">Figure 8
<p>Model performance of six SVM classifiers with an increasing number of metabolites. (<b>A</b>) ROC curves for each SVM classifier, based on average cross-validation performance. AUCs and 95% CIs are presented in the figure legend. (<b>B</b>) Predictive accuracy for each SVM. The model with the highest accuracy is highlighted in red.</p>
Full article ">Figure 9
<p>Variable importance from the SVM model with 25 metabolites. Metabolites are ranked from most to least important. The colored boxes on the right indicate metabolite concentrations in each patient group. SM, sphingomyelin; PC, phosphatidylcholine; PI, phosphatidylinositol; CE, cholesteryl ester; TG, triacylglycerol; 9,10-EpOME, 9,10-epoxyoctadecenoic acid; LPC, lysophosphatidylcholine; FA, fatty acid; Cer, ceramide; G-Glu-Glu, gamma-glutamyl-glutamic acid.</p>
Full article ">Figure 10
<p>Heatmap of the Pearson correlation coefficient matrix: (<b>A</b>) Correlations between selected metabolites and (<b>B</b>) between selected metabolites and clinical variables. Red and blue indicate negative and positive correlations, respectively. Color intensity indicates the absolute correlation value. Empty cells indicate non-significant correlations (adjusted <span class="html-italic">p</span>-values &gt; 0.05). SM, sphingomyelin; PC, phosphatidylcholine; CE, cholesteryl ester; TG, triacylglycerol; 9,10-EpOME, 9,10-epoxyoctadecenoic acid; BMI, body mass index; LDL, low-density lipoprotein cholesterol; SBP, systolic blood pressure.</p>
Full article ">
12 pages, 301 KiB  
Article
Influence of a Nutrigenetic Intervention on Self-Efficacy, Emotions, and Rewarding Behaviors in Unhealthy Eating among Mexicans: An Exploratory Pilot Study
by Ingrid Rivera-Iñiguez, Arturo Panduro, Sergio Javier Villaseñor-Bayardo, Maricruz Sepulveda-Villegas, Claudia Ojeda-Granados and Sonia Roman
Nutrients 2022, 14(1), 213; https://doi.org/10.3390/nu14010213 - 4 Jan 2022
Cited by 3 | Viewed by 3264
Abstract
The Genome-based Mexican (GENOMEX) diet is a strategy for preventing and managing obesity. Emotion and eating behavior in the context of a nutrigenetic intervention have not been thoroughly studied. We aimed to explore the influence of the GENOMEX diet on emotions, self-efficacy, and [...] Read more.
The Genome-based Mexican (GENOMEX) diet is a strategy for preventing and managing obesity. Emotion and eating behavior in the context of a nutrigenetic intervention have not been thoroughly studied. We aimed to explore the influence of the GENOMEX diet on emotions, self-efficacy, and rewarding behaviors in unhealthy eating among subjects with risk factors for obesity-related chronic diseases. Twenty-eight subjects included in the six-month GENOMEX intervention answered questions regarding emotions that influence food consumption. Additionally, the Patient Health Questionnaire (PHQ-9) and the Reward-based eating drive scale (RED) were applied. In the study, minimal, mild, moderate, and severe depression were present in 46.4%, 39.3%, 10.7%, and 3.6%, respectively. RED did not change, but it correlated with a higher intake of fats (r2 = 0.684, β = 2.066, p = 0.003). Mood influenced unhealthy eating in 71.7% of subjects, and 76.9% experienced binge episodes triggered by anxiety. Sugars were the most consumed foods during binge episodes (42.2%). Both low self-efficacy levels and binge episodes were associated with high consumption of unhealthy foods. After the intervention, 10.7% of subjects reported a high level of self-efficacy. In conclusion, a culturally acceptable and genetically compatible regional Mexican food diet reduced negative emotions and unhealthy eating while increasing self-efficacy. Full article
(This article belongs to the Special Issue The Effect of Gene-Diet Interactions in Human Health)
Show Figures

Graphical abstract

Graphical abstract
Full article ">
25 pages, 1799 KiB  
Review
Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review
by Claudia D’Alessandro, Alessia Benedetti, Antonello Di Paolo, Domenico Giannese and Adamasco Cupisti
Nutrients 2022, 14(1), 212; https://doi.org/10.3390/nu14010212 - 4 Jan 2022
Cited by 15 | Viewed by 17386
Abstract
Drugs and food interact mutually: drugs may affect the nutritional status of the body, acting on senses, appetite, resting energy expenditure, and food intake; conversely, food or one of its components may affect bioavailability and half-life, circulating plasma concentrations of drugs resulting in [...] Read more.
Drugs and food interact mutually: drugs may affect the nutritional status of the body, acting on senses, appetite, resting energy expenditure, and food intake; conversely, food or one of its components may affect bioavailability and half-life, circulating plasma concentrations of drugs resulting in an increased risk of toxicity and its adverse effects, or therapeutic failure. Therefore, the knowledge of these possible interactions is fundamental for the implementation of a nutritional treatment in the presence of a pharmacological therapy. This is the case of chronic kidney disease (CKD), for which the medication burden could be a problem, and nutritional therapy plays an important role in the patient’s treatment. The aim of this paper was to review the interactions that take place between drugs and foods that can potentially be used in renal patients, and the changes in nutritional status induced by drugs. A proper definition of the amount of food/nutrient intake, an adequate definition of the timing of meal consumption, and a proper adjustment of the drug dosing schedule may avoid these interactions, safeguarding the quality of life of the patients and guaranteeing the effectiveness of drug therapy. Hence, a close collaboration between the nephrologist, the renal dietitian, and the patient is crucial. Dietitians should consider that food may interact with drugs and that drugs may affect nutritional status, in order to provide the patient with proper dietary suggestions, and to allow the maximum effectiveness and safety of drug therapy, while preserving/correcting the nutritional status. Full article
(This article belongs to the Special Issue Nutritional Approach for Patients with Advanced CKD)
Show Figures

Figure 1

Figure 1
<p>A graphical synthesis of the possible interactions between drugs and the nutritional status, and between food and drugs in CKD patients. ⇧ = increase; ⇩ = reduce.</p>
Full article ">
9 pages, 619 KiB  
Article
Higher Iron Intake Is Independently Associated with Obesity in Younger Japanese Type-2 Diabetes Mellitus Patients
by Efrem d’Ávila Ferreira, Mariko Hatta, Yasunaga Takeda, Chika Horikawa, Mizuki Takeuchi, Noriko Kato, Hiroki Yokoyama, Yoshio Kurihara, Koichi Iwasaki, Kazuya Fujihara, Hiroshi Maegawa and Hirohito Sone
Nutrients 2022, 14(1), 211; https://doi.org/10.3390/nu14010211 - 4 Jan 2022
Cited by 4 | Viewed by 2557
Abstract
We aimed to analyze the association between dietary iron intake and obesity assessed by BMI after adjustment for nutrient intake (macronutrients and fiber) and food groups. The study design was cross-sectional. Patients with type-2 diabetes (n = 1567; 63.1% males; mean age [...] Read more.
We aimed to analyze the association between dietary iron intake and obesity assessed by BMI after adjustment for nutrient intake (macronutrients and fiber) and food groups. The study design was cross-sectional. Patients with type-2 diabetes (n = 1567; 63.1% males; mean age 62.3 ± 11.6 years) were included in the study. To assess diet, consumption of typical food groups was determined by a food frequency questionnaire. Obesity was defined as BMI ≥ 25 kg/m2. We performed a binary regression analysis between quartiles of iron intake and obesity by quartiles of age group. A direct linear association was found for the highest quartile of iron intake and obesity in the younger age group of 30 to 54 years (OR = 3.641, 95% CI = 1.020–12.990; p trend = 0.011). Multivariate analysis using food groups as opposed to nutrients revealed a positive trend for obesity in the younger age group after adjusting for lifestyle factors, energy intake and bean and vegetable intake (p trend = 0.023). In all participants, an inverse association was observed before adjustment by vegetable intake (OR = 0.453, 95% CI = 0.300–0.684; p trend = 0.001). Higher iron intake was associated with obesity independent of macronutrient and fiber intake but only in the youngest quartile of age group examined. Full article
(This article belongs to the Section Nutrition and Obesity)
Show Figures

Figure 1

Figure 1
<p>Scatter plot of Fe intake by food group according to age quartile.</p>
Full article ">
14 pages, 1171 KiB  
Article
Anti-Inflammatory Properties, Bioaccessibility and Intestinal Absorption of Sea Fennel (Crithmum maritimum) Extract Encapsulated in Soy Phosphatidylcholine Liposomes
by Ailén Alemán, Daniel Marín-Peñalver, Pilar Fernández de Palencia, María del Carmen Gómez-Guillén and Pilar Montero
Nutrients 2022, 14(1), 210; https://doi.org/10.3390/nu14010210 - 4 Jan 2022
Cited by 13 | Viewed by 3226
Abstract
A sea fennel (Crithmum maritimum) aqueous extract was prepared and loaded into soybean phosphatidylcholine liposomes. Both the free extract (FE), and the empty (L) and loaded (L-FE) liposomes were shown to be non-cytotoxic to THP-1 and Caco-2 cells. The anti-inflammatory effect [...] Read more.
A sea fennel (Crithmum maritimum) aqueous extract was prepared and loaded into soybean phosphatidylcholine liposomes. Both the free extract (FE), and the empty (L) and loaded (L-FE) liposomes were shown to be non-cytotoxic to THP-1 and Caco-2 cells. The anti-inflammatory effect was tested on THP-1 cells differentiated into macrophages. FE showed anti-inflammatory activity, revealed by the induced secretion of IL-10 cytokines in macrophages that were subsequently stimulated with LPS. Also, a decrease in TNF-α production by L was observed, evidencing that liposomes reduced the pro-inflammatory mediators’ secretion. The liposomes (L) showed protective anti-inflammatory activity and also were able to downregulate the inflammation. Furthermore, L-FE were also found to downregulate the inflammation response, as they were able to decrease TNF-α secretion in macrophages previously exposed to LPS. The simulated in vitro gastrointestinal digestion (GID) of FE diminished the chlorogenic acid content (the main polyphenolic compound of the extract) by 40%, while in L-FE, the amount of this phenolic compound increased with respect to the undigested liposomes. The amount of bioaccessible chlorogenic, however, was similar for FE and L-FE. The percentage of chlorogenic acid absorbed through a Caco-2 cell monolayer after 3 h of incubation, was significantly similar for the extract and the liposomes (~1.5%), without finding significant differences once the extract and liposomes were digested. Full article
(This article belongs to the Section Lipids)
Show Figures

Figure 1

Figure 1
<p>Percentage of viability of Caco-2 (<b>a</b>) and THP-1 cells (<b>b</b>) after incubation during 18 h with the samples at the two assayed concentrations: L (empty liposome), FE (sea fennel extract), and L-FE (liposome loaded with sea fennel extract). D 1/5 and D 1/10 indicate 1/5 and 1/10 dilutions of each sample, respectively (see Methods). Data show the mean ± S.D. (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 2
<p>Effects of incubation with samples on IL-10 production in the THP-1 cells. The THP-1 cells differentiated to macrophages were incubated with no sample (Control), empty liposome (L), free fennel extract (FE), and liposome loaded with fennel extract (L-FE) for 18 h before (<b>a</b>) and after (<b>b</b>) treated with LPS for 4 h. D 1/5 and D 1/10 indicate 1/5 and 1/10 dilutions of each sample, respectively (see Methods). Data are expressed as mean ± S.D. (<span class="html-italic">n</span> = 3) for each dilution. * <span class="html-italic">p</span> ≤ 0.05 vs. LPS stimulated control cells by Tukey test.</p>
Full article ">Figure 3
<p>Effects of incubation with samples on TNF- α production in the THP-1 cells. The THP-1 cells differentiated to macrophages were incubated with no sample (Control), empty liposome (L), free fennel extract (FE), and liposome loaded with fennel extract (L-FE) for 18 h before (<b>a</b>) and after (<b>b</b>) treated with LPS for 4 h. D 1/5 and D 1/10 indicate 1/5 and 1/10 dilutions of each sample, respectively (see Methods). Data are expressed as mean ± S.D. (<span class="html-italic">n</span> = 3) for each dilution. * <span class="html-italic">p</span> ≤ 0.05 vs. LPS stimulated control cells by Tukey test.</p>
Full article ">Figure 4
<p>Chromatographic profile at λ 253 nm of the fennel extract (FE) and liposomes loaded with the extract (L-FE), before and after gastric digestion (GD) and gastrointestinal digestion (GID). (<b>a</b>) full chromatogram, (<b>b</b>) detail of the chromatogram with the most significant changes.</p>
Full article ">
15 pages, 587 KiB  
Review
Behaviour Change Techniques in Weight Gain Prevention Interventions in Adults of Reproductive Age: Meta-Analysis and Meta-Regression
by Mamaru Ayenew Awoke, Cheryce L. Harrison, Julie Martin, Marie L. Misso, Siew Lim and Lisa J. Moran
Nutrients 2022, 14(1), 209; https://doi.org/10.3390/nu14010209 - 3 Jan 2022
Cited by 12 | Viewed by 4442
Abstract
Weight gain prevention interventions are likely to be more effective with the inclusion of behaviour change techniques. However, evidence on which behaviour change techniques (BCT) are most effective for preventing weight gain and improving lifestyle (diet and physical activity) is limited, especially in [...] Read more.
Weight gain prevention interventions are likely to be more effective with the inclusion of behaviour change techniques. However, evidence on which behaviour change techniques (BCT) are most effective for preventing weight gain and improving lifestyle (diet and physical activity) is limited, especially in reproductive-aged adults. This meta-analysis and meta-regression aimed to identify BCT associated with changes in weight, energy intake and physical activity in reproductive-aged adults. BCT were identified using the BCT Taxonomy (v1) from each intervention. Meta-regression analyses were used to identify BCT associated with change in weight, energy intake and physical activity. Thirty-four articles were included with twenty-nine articles for the meta-analysis. Forty-three of the ninety-three possible BCT listed in the taxonomy were identified in the included studies. Feedback on behaviour and Graded tasks were significantly associated with less weight gain, and Review behaviour goals was significantly associated with lower energy intake. No individual BCT were significantly associated with physical activity. Our analysis provides further evidence for which BCT are most effective in weight gain prevention interventions. The findings support that the use of key BCT within interventions can contribute to successful weight gain prevention in adults of reproductive age. Full article
(This article belongs to the Special Issue Combined Nutrition and Exercise Interventions in Community Groups)
Show Figures

Figure 1

Figure 1
<p>Identified behaviour change strategies in lifestyle interventions from the included studies (<span class="html-italic">n</span> = 34).</p>
Full article ">Figure 1 Cont.
<p>Identified behaviour change strategies in lifestyle interventions from the included studies (<span class="html-italic">n</span> = 34).</p>
Full article ">
13 pages, 2348 KiB  
Article
Effect of Standardized Hydrangea serrata (Thunb.) Ser. Leaves Extract on Body Weight and Body Fat Reduction in Overweight or Obese Humans: A Randomized Double-Blind Placebo-Controlled Study
by Hee-Soo Han, Kyung-Sook Chung, Yu-Kyong Shin, Jae-Sik Yu, Seung-Hyun Kang, Sun-Hee Lee and Kyung-Tae Lee
Nutrients 2022, 14(1), 208; https://doi.org/10.3390/nu14010208 - 3 Jan 2022
Cited by 5 | Viewed by 4070
Abstract
Obesity is a major health problem that is caused by body fat accumulation and that can lead to metabolic diseases. Owing to several side effects of the currently used antiobesity drugs, natural plants have risen as safe and potential candidates to alleviate obesity. [...] Read more.
Obesity is a major health problem that is caused by body fat accumulation and that can lead to metabolic diseases. Owing to several side effects of the currently used antiobesity drugs, natural plants have risen as safe and potential candidates to alleviate obesity. We have previously reported the antiobesity effect of Hydrangea serrata (Thunb.) Ser. leaves extract (WHS) and its underlying mechanisms. As an extension of our preclinical studies, this study aimed to investigate the effect of WHS on body weight and body fat reduction in overweight or obese humans. A total of 93 healthy overweight or obese males and females, aged 19–65 years, with body mass indexes (BMIs) ≥ 25 and <32 kg/m2, were recruited and received either an oral administration of 600 mg of WHS, or placebo tablets for 12 weeks. Daily supplementation with WHS decreased body weights, body fat masses, and BMIs compared with the placebo-treated group. The hip circumferences, visceral fat areas, abdominal fat areas, and visceral-to-subcutaneous ratios decreased after WHS supplementation. No significant side effects were observed during or after the 12 weeks of WHS intake. In conclusion, WHS, which has beneficial effects on body weight and body fat reduction, could be a promising antiobesity supplement that does not produce any side effects. Full article
(This article belongs to the Section Phytochemicals and Human Health)
Show Figures

Figure 1

Figure 1
<p>Process of study.</p>
Full article ">Figure 2
<p>Flow diagram of the enrolled participants.</p>
Full article ">Figure 3
<p>Changes in body fat masses and fat percentages. Changes in (<b>A</b>,<b>B</b>) fat mass and (<b>C</b>,<b>D</b>) fat percentage were measured in placebo- and WHS-treated groups at baseline and 12 weeks. Values are present as mean ± SD; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 derived from paired <span class="html-italic">t</span>-test within groups (Weeks 0 vs. 12), and <sup>*</sup> <span class="html-italic">p</span> &lt; 0.05 derived from a two-sample <span class="html-italic">t</span>-test or Wilcoxon rank-sum test between groups (Placebo (<span class="html-italic">n</span> = 45) vs. WHS (<span class="html-italic">n</span> = 48)).</p>
Full article ">Figure 4
<p>Changes in body weights and BMIs. Changes in (<b>A</b>,<b>B</b>) weight and (<b>C</b>,<b>D</b>) BMI were measured in placebo- and WHS-treated groups at baseline, 6, and 12 weeks. Values are present as mean ± SD; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 derived from paired <span class="html-italic">t</span>-test within groups (Weeks 0 vs. 12), and <sup>*</sup> <span class="html-italic">p</span> &lt; 0.05 derived from a two-sample <span class="html-italic">t</span>-test or Wilcoxon rank-sum test between groups (Placebo (<span class="html-italic">n</span> = 45) vs. WHS (<span class="html-italic">n</span> = 48)).</p>
Full article ">Figure 5
<p>Changes in waist and hip circumferences. Changes in (<b>A</b>,<b>B</b>) waist circumference and (<b>C</b>,<b>D</b>) hip circumference were measured in placebo- and WHS-treated groups at baseline, 6, and 12 weeks. Values are present as mean ± SD; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 derived from paired <span class="html-italic">t</span>-test within groups (Weeks 0 vs. 6 or 12), and <sup>*</sup> <span class="html-italic">p</span> &lt; 0.05 derived from a two-sample <span class="html-italic">t</span>-test or Wilcoxon rank-sum test between groups (Placebo (<span class="html-italic">n</span> = 45) vs. WHS (<span class="html-italic">n</span> = 48)).</p>
Full article ">Figure 6
<p>Changes in body fat areas. (<b>A</b>) Visceral fat area, (<b>B</b>) subcutaneous fat area, (<b>C</b>) total abdominal fat area, and (<b>D</b>) visceral-to-subcutaneous fat ratio were measured in placebo- and WHS-treated groups at baseline and 12 weeks. (<b>E</b>–<b>H</b>) Changes in these parameters between Weeks 0 and 12. Values are present as mean ± SD; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 derived from paired <span class="html-italic">t</span>-test within groups (Weeks 0 vs. 12), and <sup>*</sup> <span class="html-italic">p</span> &lt; 0.05 derived from a two-sample <span class="html-italic">t</span>-test or Wilcoxon rank-sum test between groups (Placebo (<span class="html-italic">n</span> = 45) vs. WHS (<span class="html-italic">n</span> = 48)).</p>
Full article ">
10 pages, 902 KiB  
Article
Malnutrition and Increased Risk of Adverse Outcomes in Elderly Patients Undergoing Elective Colorectal Cancer Surgery: A Case-Control Study Nested in a Cohort
by Cristina Martínez-Escribano, Francisco Arteaga Moreno, Marcos Pérez-López, Cristina Cunha-Pérez, Ángel Belenguer-Varea, David Cuesta Peredo, Francisco Javier Blanco González and Francisco J. Tarazona-Santabalbina
Nutrients 2022, 14(1), 207; https://doi.org/10.3390/nu14010207 - 3 Jan 2022
Cited by 30 | Viewed by 4068
Abstract
Background: Malnutrition increases worse outcomes during hospital admission for elective colorectal cancer (CRC) surgery in older adults. Methods: This work was designed an observational, monocentric, case-control study nested in a cohort of patients undergoing elective surgery for CRC disease at the Hospital Universitario [...] Read more.
Background: Malnutrition increases worse outcomes during hospital admission for elective colorectal cancer (CRC) surgery in older adults. Methods: This work was designed an observational, monocentric, case-control study nested in a cohort of patients undergoing elective surgery for CRC disease at the Hospital Universitario de la Ribera (HULR) (Alzira, Valencia, Spain) between 2011 and 2019. The study considered patients with a CONUT score in the range of moderate to severe malnutrition (>4 points), with control patients with normal nutritional situations or mild malnutrition. Results: Moderate-to-severe malnutrition cases presented a greater length of stay (LOS), a higher incidence of adverse events (both medical and surgical complications), a higher incidence of surgical-wound infection, a greater need for blood transfusion, and a greater amount of transfused packed red blood cells. During hospitalization, the percentage of patients without nutritional risk decreased from 46 to 9%, and an increase in mild, moderate, and severe risk was observed. Patients with severe nutritional risk at hospital admission had significantly increased mortality at 365 days after discharge (HR: 2.96 (95% CI 1.14–7.70, p = 0.002)). After adjusting for sex, age, and Charlson index score, patients with severe nutritional risk at admission maintained a higher mortality risk (HR: 3.08 (95% CI 1.10–8.63, p = 0.032)). Conclusion: Malnutrition prevalence is high in older adults undergoing CRC elective surgery. Furthermore, this prevalence increases during hospital admission. Malnutrition is linked to worse outcomes, such as LOS, surgical and clinical complications, and mortality. For this reason, nutritional interventions are very important in the perioperative period Full article
(This article belongs to the Section Clinical Nutrition)
Show Figures

Figure 1

Figure 1
<p>Changes in nutritional risk estimated by CONUT score.</p>
Full article ">Figure 2
<p>Survival curve using the Kaplan-Meier analysis based on the nutritional status estimated by CONUT. (<b>A</b>) Survival curve with the nutritional estimate using CONUT at hospital admission. <b>(B)</b> Analysis with the nutritional estimate using CONUT at hospital discharge.</p>
Full article ">Figure 2 Cont.
<p>Survival curve using the Kaplan-Meier analysis based on the nutritional status estimated by CONUT. (<b>A</b>) Survival curve with the nutritional estimate using CONUT at hospital admission. <b>(B)</b> Analysis with the nutritional estimate using CONUT at hospital discharge.</p>
Full article ">
8 pages, 228 KiB  
Article
The Australian Feeding Infants and Toddler Study (OzFITS 2021): Breastfeeding and Early Feeding Practices
by Merryn J. Netting, Najma A. Moumin, Emma J. Knight, Rebecca K. Golley, Maria Makrides and Tim J. Green
Nutrients 2022, 14(1), 206; https://doi.org/10.3390/nu14010206 - 3 Jan 2022
Cited by 21 | Viewed by 5073
Abstract
The Australian Feeding Infants and Toddler Study 2021 (OzFITS 2021) is a nationwide survey of Australian caregivers’ infant and toddler feeding practices. Here, we describe breastfeeding rates and duration, use of breastmilk substitutes, and introduction of complementary (solid) foods, including common food allergens. [...] Read more.
The Australian Feeding Infants and Toddler Study 2021 (OzFITS 2021) is a nationwide survey of Australian caregivers’ infant and toddler feeding practices. Here, we describe breastfeeding rates and duration, use of breastmilk substitutes, and introduction of complementary (solid) foods, including common food allergens. Caregivers (n = 1140) were recruited by a digital marketing company and were interviewed using a structured telephone questionnaire to obtain information. Breastfeeding was initiated in 98% of infants, but the duration of exclusive breastfeeding to six months was less than 1%. Nearly 40% of children continued to receive breastmilk beyond one year, with 10% of toddlers receiving breastmilk at two years. One-quarter of infants were introduced to solid foods between 4 to 5 months, and nearly all infants had received solid foods by 7 months. New guidelines encourage the early introduction of potential food allergens to reduce the risk of allergy, and by 12 months, over 90% of children had been given eggs and peanuts. One-third of children received no breastmilk substitutes during their first year. One-third of infants first received breastmilk substitutes following birth and before discharge from the hospital. Of these infants, 30% ceased breastmilk substitute use after discharge. Our findings suggest a high rate of continued breastfeeding with 44% receiving breastmilk beyond 1 year. One approach to increase the duration of exclusive breastfeeding is to reduce breastmilk substitute use while in hospital. Full article
(This article belongs to the Special Issue The Australian Feeding Infants and Toddlers Study (OZFITS), 2021)
9 pages, 562 KiB  
Article
Testing the Accuracy of a Bedside Screening Tool Framework to Clinical Records for Identification of Patients at Risk of Malnutrition in a Rural Setting: An Exploratory Study
by Laura Alston, Megan Green, Melanie Nichols, Stephanie R. Partridge, Alison Buccheri, Kristy A. Bolton, Vincent L. Versace, Michael Field, Ambrose J. Launder, Amy Lily, Steven Allender and Liliana Orellana
Nutrients 2022, 14(1), 205; https://doi.org/10.3390/nu14010205 - 2 Jan 2022
Cited by 2 | Viewed by 2762
Abstract
This study aimed to explore the diagnostic accuracy of the Patient-Generated Subjective Global Assessment (PG-SGA) malnutrition risk screening tool when used to score patients based on their electronic medical records (EMR), compared to bedside screening interviews. In-patients at a rural health service were [...] Read more.
This study aimed to explore the diagnostic accuracy of the Patient-Generated Subjective Global Assessment (PG-SGA) malnutrition risk screening tool when used to score patients based on their electronic medical records (EMR), compared to bedside screening interviews. In-patients at a rural health service were screened at the bedside (n = 50) using the PG-SGA, generating a bedside score. Clinical notes within EMRs were then independently screened by blinded researchers. The accuracy of the EMR score was assessed against the bedside score using area under the receiver operating curve (AUC), sensitivity, and specificity. Participants were 62% female and 32% had conditions associated with malnutrition, with a mean age of 70.6 years (SD 14.9). The EMR score had moderate diagnostic accuracy relative to PG-SGA bedside screen, AUC 0.74 (95% CI: 0.59–0.89). The accuracy, specificity and sensitivity of the EMR score was highest for patients with a score of 7, indicating EMR screen is more likely to detect patients at risk of malnutrition. This exploratory study showed that applying the PG-SGA screening tool to EMRs had enough sensitivity and specificity for identifying patients at risk of malnutrition to warrant further exploration in low-resource settings. Full article
(This article belongs to the Section Clinical Nutrition)
Show Figures

Figure 1

Figure 1
<p>Receiver Operating Characteristic (ROC) curve for the malnutrition PG-SGA score based on the EMR review compared to PG-SGA bed-side screen.</p>
Full article ">
16 pages, 1609 KiB  
Article
Extreme Birth Weight and Metabolic Syndrome in Children
by Teofana Otilia Bizerea-Moga, Laura Pitulice, Cristina Loredana Pantea, Orsolya Olah, Otilia Marginean and Tudor Voicu Moga
Nutrients 2022, 14(1), 204; https://doi.org/10.3390/nu14010204 - 2 Jan 2022
Cited by 11 | Viewed by 3752
Abstract
Small and large birth weights (BWs) for gestational age (GA) represent extremes, but the correlation between extreme BW and metabolic syndrome (MetS) has not been fully elucidated. In this study, we examined this correlation in obese children based on changes in their metabolic [...] Read more.
Small and large birth weights (BWs) for gestational age (GA) represent extremes, but the correlation between extreme BW and metabolic syndrome (MetS) has not been fully elucidated. In this study, we examined this correlation in obese children based on changes in their metabolic profile from childhood to adolescence. A retrospective observational study was performed on 535 obese patients aged 0–18 years in the Clinical and Emergency Hospital for Children “Louis Turcanu” in Timisoara, Romania, based on clinical and biological data from January 2015 to December 2019. We emphasized the links between extreme BW and obesity, extreme BW and cardiometabolic risk, obesity and cardiometabolic risk, and extreme BW, obesity and MetS. Children born large for gestational age (LGA) predominated over those born small for gestational age (SGA). Our findings showed that BW has an independent effect on triglycerides and insulin resistance, whereas obesity had a direct influence on hypertension, impaired glucose metabolism and hypertriglyceridemia. The influences of BW and obesity on the development of MetS and its components are difficult to separate; therefore, large prospective studies in normal-weight patients are needed. Full article
(This article belongs to the Special Issue Biomarker of Stress, Metabolic Syndrome and Human Health)
Show Figures

Figure 1

Figure 1
<p>Percentage distribution of patients obese small for gestational age (oSGA), obese appropriate for gestational age (oAGA), and obese large for gestational age (oLGA) included in the study according to birth weight (BW) for gestational age (GA).</p>
Full article ">Figure 2
<p>Correlation between BMI, age, and BW.</p>
Full article ">Figure 3
<p>Correlation between BW and triglycerides.</p>
Full article ">Figure 4
<p>Correlation between BMI and (<b>a</b>) systolic blood pressure (BP), (<b>b</b>) diastolic BP, (<b>c</b>) fasting glucose, (<b>d</b>) 2 h glucose, (<b>e</b>) insulinemia, (<b>f</b>) HOMA index and (<b>g</b>) triglycerides.</p>
Full article ">Figure 5
<p>The percentage distribution of metabolic syndrome (MetS) and components among the study groups.</p>
Full article ">
14 pages, 1630 KiB  
Article
Physical Performance and Non-Esterified Fatty Acids in Men and Women after Transcatheter Aortic Valve Implantation (TAVI)
by Michaela Härdrich, Anja Haase-Fielitz, Jens Fielitz, Michael Boschmann, Olga Pivovarova-Ramich, Andreas F. H. Pfeiffer, Natalia Rudovich, Karsten H. Weylandt and Christian Butter
Nutrients 2022, 14(1), 203; https://doi.org/10.3390/nu14010203 - 2 Jan 2022
Cited by 1 | Viewed by 2772
Abstract
Background: Men and women with valvular heart disease have different risk profiles for clinical endpoints. Non-esterified fatty acids (NEFA) are possibly involved in cardio-metabolic disease. However, it is unclear whether NEFA concentrations are associated with physical performance in patients undergoing transcatheter aortic valve [...] Read more.
Background: Men and women with valvular heart disease have different risk profiles for clinical endpoints. Non-esterified fatty acids (NEFA) are possibly involved in cardio-metabolic disease. However, it is unclear whether NEFA concentrations are associated with physical performance in patients undergoing transcatheter aortic valve implantation (TAVI) and whether there are sex-specific effects. Methods: To test the hypothesis that NEFA concentration is associated with sex-specific physical performance, we prospectively analysed data from one hundred adult patients undergoing TAVI. NEFA concentrations, physical performance and anthropometric parameters were measured before and 6 and 12 months after TAVI. Physical performance was determined by a six-minute walking test (6-MWT) and self-reported weekly bicycle riding time. Results: Before TAVI, NEFA concentrations were higher in patients (44 women, 56 men) compared to the normal population. Median NEFA concentrations at 6 and 12 months after TAVI were within the reference range reported in the normal population in men but not women. Men but not women presented with an increased performance in the 6-MWT over time (p = 0.026, p = 0.142, respectively). Additionally, men showed an increased ability to ride a bicycle after TAVI compared to before TAVI (p = 0.034). NEFA concentrations before TAVI correlated with the 6-MWT before TAVI in women (Spearman’s rho −0.552; p = 0.001) but not in men (Spearman’s rho −0.007; p = 0.964). No association was found between NEFA concentrations and physical performance 6 and 12 months after TAVI. Conclusions: NEFA concentrations improved into the reference range in men but not women after TAVI. Men but not women have an increased physical performance after TAVI. No association between NEFA and physical performance was observed in men and women after TAVI. Full article
(This article belongs to the Section Lipids)
Show Figures

Figure 1

Figure 1
<p>Patient flow through the study.</p>
Full article ">Figure 2
<p>Sex-specific changes in non-esterified fatty acids (NEFA) over 12 months after Transcatheter Aortic Valve Implantation.</p>
Full article ">Figure 3
<p>Sex-specific changes in physical performance over 12 months: (<b>a</b>) Six-minute walking test (6-MWT); (<b>b</b>) bicycle riding. The * means outliers.</p>
Full article ">Figure 4
<p>Association between NEFA concentration before TAVI and distance in six-minute walk test.</p>
Full article ">
13 pages, 628 KiB  
Article
Vitamin D Supplementation in Exclusively Breastfed Infants Is Associated with Alterations in the Fecal Microbiome
by Tengfei Ma, Sihan Bu, Nigel Paneth, Jean M. Kerver and Sarah S. Comstock
Nutrients 2022, 14(1), 202; https://doi.org/10.3390/nu14010202 - 1 Jan 2022
Cited by 9 | Viewed by 4008
Abstract
Breastfeeding and introduction of solid food are the two major components of infant feeding practices that influence gut microbiota composition in early infancy. However, it is unclear whether additional factors influence the microbiota of infants either exclusively breastfed or not breastfed. We obtained [...] Read more.
Breastfeeding and introduction of solid food are the two major components of infant feeding practices that influence gut microbiota composition in early infancy. However, it is unclear whether additional factors influence the microbiota of infants either exclusively breastfed or not breastfed. We obtained 194 fecal samples from infants at 3–9 months of age, extracted DNA, and sequenced the V4 region of the 16S rRNA gene. Feeding practices and clinical information were collected by questionnaire and abstraction of birth certificates. The gut microbiota of infants who were exclusively breastfed displayed significantly lower Shannon diversity (p-adjust < 0.001) and different gut microbiota composition compared to infants who were not breastfed (p-value = 0.001). Among the exclusively breastfed infants, recipients of vitamin D supplements displayed significantly lower Shannon diversity (p-adjust = 0.007), and different gut microbiota composition structure than non-supplemented, breastfed infants (p-value = 0.02). MaAslin analysis identified microbial taxa that associated with breastfeeding and vitamin D supplementation. Breastfeeding and infant vitamin D supplement intake play an important role in shaping infant gut microbiota. Full article
(This article belongs to the Section Micronutrients and Human Health)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Infant alpha and beta diversity by infant breastfeeding and Vitamin D supplement. FDR adjusted <span class="html-italic">p</span>-value for alpha diversity was displayed in upper-left. (<b>A</b>) The Shannon index was used for alpha diversity. All the participants were included in the analysis (N = 191). Group differences were tested by Kruskal-Wallis test. We then performed post hoc test for multiple comparisons. After FDR adjustment, no breastfeeding group has significant difference with exclusive breastfeeding (adjusted <span class="html-italic">p</span>-value &lt; 0.01). Partial breastfeeding group has no significant difference with exclusive breastfeeding group (<span class="html-italic">p</span>-value = 0.4, adjusted <span class="html-italic">p</span>-value = 0.9) and no breastfeeding group (<span class="html-italic">p</span>-value = 0.03, adjusted <span class="html-italic">p</span>-value = 0.09). (<b>B</b>) The Chao1 index was used for alpha diversity. All the participants were included in the analysis (N = 191). Post hoc test did not find any significant difference between groups. (<b>C</b>) The Shannon index was used for alpha diversity. Only breastfeeding participants were included in this subgroup (N = 92). Group differences were tested by Wilcoxon rank test. (<b>D</b>) The Chao1 index was used for alpha diversity. Only breastfeeding participants were included in this subgroup analysis (N = 92). (<b>E</b>) Principal component analysis (PCoA) ordinations of variation based on the Bray–Curtis distance matrix for all infants. R<sup>2</sup> and <span class="html-italic">p</span>-value were calculated by univariate PERMANOVA test with 999 permutations.</p>
Full article ">
Previous Issue
Back to TopTop